GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the Fab fragment of anti-CD20 antibody ofatumumab

Analyse Crystal structure of the Fab fragment of anti-CD20 antibody ofatumumab in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3GIZ
Type
protein
Length
427 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Fab fragment of anti-CD20 antibody ofatumumab, light chain; Fab fragment of anti-CD20…
Ligands
ZN
Pockets
4 · best druggability 0.59

Structure

x-ray diffraction · 2 distinct chains · 6% helix, 51% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LFab fragment of anti-CD20 antibody ofatumumab, light chainprotein2115% helix, 51% strand—
HFab fragment of anti-CD20 antibody ofatumumab, heavy chainprotein2167% helix, 51% strand—

Ligands and binding sites

  • ZN · Zinc ion · metal · 3 copies · chains L, H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14620.590.7545empty
2580.560.9020empty
31290.410.7520empty
41020.360.7423empty

Interfaces

1 interface between chains.

  • L–H · 1756 Ų buried · 13 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide (disulfide).

Compared structures

  • 3GIZ · Crystal structure of the Fab fragment of anti-CD20 antibody Ofatumumab · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.